Presentation TCT 2017 Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis! Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento November 01, 2017
Presentation TCT 2017 Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis! Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb November 01, 2017
Presentation TCT 2017 Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy? Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer November 01, 2017
Presentation TCT 2017 Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other Presenter: Alfredo Trento, David J. Cohen November 01, 2017
Presentation TCT 2017 Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis Presenter: Bernard Prendergast, Brian K. Whisenant, Victoria Delgado November 01, 2017
Presentation TCT 2017 Asymptomatic Severe Aortic Stenosis: To Treat or to Watch? Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz November 01, 2017
Presentation TCT 2017 Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR? Presenter: Bernard Prendergast, Brian K. Whisenant, David J. Cohen November 01, 2017
Presentation TCT 2017 Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle November 01, 2017
Presentation TCT 2017 Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions Presenter: Bernard Prendergast, Brian K. Whisenant November 01, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
Presentation TCT 2017 TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study) Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD October 31, 2017
Presentation TCT 2017 TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard October 31, 2017
Presentation TCT 2017 TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry Presenter: Jean-Claude Laborde, Eric Van Belle, Saif Anwaruddin October 31, 2017
Presentation TCT 2017 TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD October 31, 2017
Presentation TCT 2017 TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis Presenter: Jean-Claude Laborde, Eric Van Belle, Tomohiko Taniguchi, MD October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support? Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble October 31, 2017
Presentation TCT 2017 Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR Presenter: Nick Curzen, Rod H. Stables October 31, 2017
Presentation TCT 2017 Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR Presenter: Nick Curzen, Rod H. Stables October 31, 2017